Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients at Risk for Thrombosis”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Large-scale testing (Phase 3)Study completedNCT01024452
What this trial is testing

Randomized Comparison of Warfarin Dosing Quality Between the Hamilton Nomogram and a Commercial Computer System

Who this might be right for
Patients at Risk for Thrombosis
Population Health Research Institute 1,298
Large-scale testing (Phase 3)Study completedNCT00050817
What this trial is testing

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Who this might be right for
Arteriosclerosis
Sanofi 15,603
Post-approval studies (Phase 4)Study completedNCT00585182
What this trial is testing

Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT

Who this might be right for
ObesityVenous ThrombosisAnticoagulants
University of Utah 28
Not applicableStudy completedNCT00657436
What this trial is testing

Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement

Who this might be right for
Myocardial IschemiaAcute Coronary SyndromeMyocardial Infarction+2 more
University of Zurich 403
Not applicableWithdrawnNCT05536791
What this trial is testing

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Not applicableEnded earlyNCT05966740
What this trial is testing

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 6
Large-scale testing (Phase 3)Study completedNCT00110513
What this trial is testing

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Who this might be right for
Antithrombin III Deficiency
rEVO Biologics 18
Not applicableStudy completedNCT01972282
What this trial is testing

Registry on WATCHMAN Outcomes in Real-Life Utilization

Who this might be right for
Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke
Boston Scientific Corporation 1,025
Large-scale testing (Phase 3)Study completedNCT02555878
What this trial is testing

Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 841
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableLooking for participantsNCT06232551
What this trial is testing

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Who this might be right for
Venous Thromboembolic DiseasePulmonary Embolism and ThrombosisDeep Vein Thrombosis+1 more
Scott C. Woller, MD 152,000
Post-approval studies (Phase 4)Study completedNCT02415400
What this trial is testing

Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Who this might be right for
Acute Coronary Syndromes
Bristol-Myers Squibb 4,614
Not applicableStudy completedNCT00604370
What this trial is testing

Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge

Who this might be right for
Venous Thromboembolism
Brigham and Women's Hospital 2,500
Not applicableStudy completedNCT03044574
What this trial is testing

Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism

Who this might be right for
Venous ThromboembolismVenous Thrombosis
Pirogov Russian National Research Medical University 407
Not applicableStudy completedNCT02095925
What this trial is testing

Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism

Who this might be right for
CancerDeep Venous ThrombosisPulmonary Embolism
Harry R. Buller 900
Not applicableLooking for participantsNCT05512923
What this trial is testing

Incidence and Risk Factors of Venous Thrombosis of the Lower Limbs After Hospitalization in Medical Patients at Risk

Who this might be right for
Patients Hospitalized for More Than 48 HoursAcute Medical Illness
University of Monastir 2,000
Not applicableStudy completedNCT03070834
What this trial is testing

RIPT Feasibility Trial

Who this might be right for
Pulmonary EmbolismTraumaVenous Thromboembolism
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 42
Not applicableUnknownNCT00653601
What this trial is testing

Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery

Who this might be right for
BleedingThrombosis
Cedars-Sinai Medical Center 20
Not applicableStudy completedNCT01460966
What this trial is testing

Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)

Who this might be right for
Coronary Artery Disease
Yokohama City University Medical Center 200
Load More Results